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PREDICTORS AND DETERMINANTS FOR RECOVERY AND SURVIVAL AFTER 
UPPER ABDOMINAL SURGERY 
 
 
“The turning point: This period of convalescence has been recognized by surgeons for many 
centuries. At present, interns and residents state that women at this period of convalescence 
show a “positive lipstick sign”, meaning that the patient now takes renewed interest in her 
surroundings. She turns a corner toward recovery”. 
 
 
- Francis D. Moore, North-American surgeon and convalescence researcher, describing 
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- ERAS: Enhanced Recovery after Surgery 
- ERP: Enhanced recovery program 
- WL: Weight loss 
- CT: Computed tomography 
- BMI: Body mass index 
- SMT: Skeletal muscle tissue 
- VAT: Visceral adipose tissue 
- SAT: Subcutaneous adipose tissue 
- HRQOL: Health-related quality of life 
- SF 36: Short form 36 
- PCS: Physical component summary 






- Upper abdominal surgery: Gastroesophageal and hepatopancreaticobiliary surgery.  
- Enhanced recovery programs: Concepts based upon protocols of evidence-based care 
items applied perioperatively to achieve optimal stress reduction following surgery (8) 
- Body composition analyses: Analyses of the amount of fat and lean tissue in the 
human body (9). 
- Cancer cachexia: Multifactorial syndrome with ongoing loss of skeletal muscle mass 
(with or without loss of fat mass) that cannot be fully reversed by conventional 
nutritional support and leads to progressive functional impairment. Pathophysiology is 
characterized by a negative protein and energy balance driven by a variable 
combination of reduced food intake and abnormal metabolism (10). 
- Appendicular skeletal mass: Skeletal muscle tissue from arms and legs (9). 
- Lean tissue: Body tissue without fat and bone mineral (9). 
- Myopenia or sarcopenia: Low relative amount of skeletal muscle tissue or loss of 
skeletal muscle tissue (used in both contexts). Both terms lack universally accepted 
definitions and cut-offs (9;11).  
- Myosteatosis: Fatty infiltration in skeletal muscle tissue (12). 






Patients with colorectal malignancies have benefited from major improvements in surgical 
technique and perioperative care during the last decades. These improvements have 
contributed to better prognosis and faster recovery, with five-year survival around 80% for 
localized colorectal cancer and reports of discharge from hospital within 24 hours after colon 
resections.   
 
In contrast, patients with upper abdominal malignant disease often experience delayed 
recovery and long-standing functional impairment. Postoperative complications are frequent 
and the prognosis is often poor.  Only a small fraction of patients will survive for five years or 
more after surgery. Delayed recovery, postoperative morbidity and poor prognosis will 
naturally affect patients’ health-related quality of life (HRQOL).   
 
Upper abdominal malignancies are often associated with cachexia and patients are often 
weakened preoperatively, characterized by extensive weight loss, abnormal serum-albumin 
and sarcopenia (low relative amount of skeletal muscle tissue). This may contribute to 
delayed recovery, increased morbidity, reduced HRQOL and ultimately reduced survival. 
 
Improved survival is an essential objective in upper abdominal surgery. Enhanced recovery, 
reduced morbidity and improved HRQOL are important in itself, but it may also lead to 





Improvements in recovery and survival after upper abdominal surgery relies on high-quality 
research.  While overall survival is a robust and objective outcome measure in clinical 
research, recovery is much more difficult to define.  
 
Avoidance of postoperative morbidity is crucial for achieving enhanced recovery. Recent 
reports have also indicated that reduction of postoperative morbidity may also lead to 
improved long-term survival, even for patients initially surviving the double hit of major 
surgery and postoperative complications.  
 
This thesis aims to explore predictors and determinants for recovery and survival after upper 
abdominal surgery. It aims to explore how patients and dedicated professionals define 
recovery. Furthermore, it aims to explore new and old indicators of risk and prognosis with 
emphasis on methods to assess cachexia and sarcopenia. Finally, it aims to explore 
correlations between postoperative morbidity, HRQOL and overall survival after major upper 






2.1 Upper abdominal surgery 
Upper abdominal surgery is very often associated with postoperative complications and 
longstanding functional impairment (13;14). Survival after surgery for upper abdominal 
malignancies, even after operations with curative intent, is often limited (15;16). Patients with 
upper abdominal malignancies are often weakened by cachexia and sarcopenia (low muscle 
mass) (17;18). Both cachexia and sarcopenia have been associated with postoperative 
complications and reduced survival (2;19-22). Strict evaluation of surgical risk and benefit is 
essential in upper abdominal surgery.  
 
 Systematic follow-up is essential after colorectal cancer resections since metastatic disease 
can be treated with curative intent (23). Little survival benefit has been shown from strict 
oncologic follow-up after upper abdominal cancer surgery (24;25). There is a need to find 
other ways to improve long-term survival. Patients with upper abdominal malignancies may 
be offered adjuvant oncological therapy, sometimes with limited benefit and unwanted side 
effects (26-28). Patients and surgeons often face difficult decisions in upper abdominal 
surgery, which make postoperative assessment of expected survival especially important. 
 
2.2 Recovery 
Enhanced recovery concepts are based upon protocols of evidence-based care items applied 
perioperatively to achieve optimal stress reduction following surgery with subsequent 
reductions in morbidity and accelerated recovery (8). Traditionally, it has been considered 
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that all protocol items are equally important and that synergistic effects on recovery are 
optimal only when all items are implemented (8;29). These views have lately been challenged 
as some items are seen as outdated and others as standard of care.  
 
Francis D Moore defined surgical convalescence in 1958 in the following way (1): 
“Convalescence includes all the interlocking physical, chemical, metabolic, and psychological 
factors commencing with the injury, or even slightly before the injury, and terminating only 
when the individual has returned to normal physical well-being, social and economic 
usefulness, and psychological habitus.” Whilst FD Moore half a century ago focused on the 
importance of functional recovery, the length of hospital stay (LOS) has been the dominant 
outcome in convalescence research in later years (30).  
 
High-quality research on surgical convalescence may lead to improved outcome for our 
patients, but an essential first step in such research development is international consensus on 
definitions, objectives and means (30).  
 
2.3 Risk assessment: Cachexia and sarcopenia 
Preoperative weight loss has been associated with increased postoperative mortality since 
North-American surgeon Hiram Studley’s paper on patients operated for peptic ulcer in 1936 
(31). Abnormal serum-albumin has been associated with unfavorable postoperative outcome 
for more than a decade (32;33).  An involuntary weight loss of five percent or more has been 
recognized to be associated with reduced survival for more than thirty years (34) and it has 




Sarcopenia has been associated with postoperative complications and reduced survival after 
cancer surgery (2;19-22), but the results have been somewhat conflicting (18;35;36). 
Sarcopenia has also been associated with increased chemotherapy-associated toxicity and 
decreased time to tumor progression in patients receiving palliative chemotherapy (37). In 
contrast, sarcopenia has also been linked to increased pathological response and progression-
free survival in patients receiving neoadjuvant chemotherapy (38). While visceral adiposity 
has been associated with diabetes and diabetes again has been associated with unfavorable 
outcome after surgery, evaluations of a direct association between adipose tissue indices and 
unfavorable outcome have shown conflicting results (39-41). Most recently, sarcopenia has 
been associated with pulmonary complications after esophagectomies (42) and the 
combination of low muscularity and visceral obesity has been linked to increased occurrence 
of pancreatic fistulas after pancreaticoduodenectomies (43;44). A recent study investigated 
obesity, sarcopenia and outcome after colorectal resections within an enhanced recovery 
program. While isolated obesity or sarcopenia was not associated with increased morbidity or 
mortality, a dramatic increase in mortality was observed in patients with the combination of 
both (sarcopenic obesity) (12).   
 
An ongoing loss of both skeletal muscle and adipose tissue during neoadjuvant chemotherapy 
treatment for both gastric and pancreatic cancer has been shown (35;36). Still, such loss has 
not been consistently linked to either complications or survival (35;36). Extensive loss of 
skeletal muscle and adipose tissue during adjuvant treatment for gastric adenocarcinoma has 
also been described, but such loss has – again - yet to be linked to clinical outcome (45). Most 
recently, loss of skeletal muscle tissue after colorectal cancer resections has been observed in 




Analyses of body composition, weight loss and serum-albumin 
Three different methods for assessing skeletal muscle tissue on preoperative CT images has 
emerged in the recent years; the measurement of lumbar skeletal muscle index, the total psoas 
muscle area or the total psoas muscle volume (47-49). Many different cut-offs have been 
presented, some almost identical to others, and many have not been validated in other studies 
(20;47;50;51).      
 
Assessment of preoperative weight loss depends on patients’ recollection of pre-morbid 
weight, which might be inaccurate. Serum-albumin can be influenced by many factors such as 
nutrition, dehydration and inflammation and therefore hard to interpret (52). Therefore, 
supplementary tools are needed in both research and clinical practice (10). Since almost all 
patients subjected to upper abdominal surgery will be examined with at least one preoperative 
CT scan for diagnostic and staging purposes, CT-based body composition indices may 
represent an opportunity for new risk and prognosis assessment tools. There is increasing 
evidence that sarcopenia might be an indicator of poor prognosis, independent of disease 
stage in some malignancies (22;49).  Suggestions of genetic risk factors and potential 
therapeutic interventions (19) for such sarcopenia is especially interesting. Still, further 
validation of both methods and disease-specific cut-offs are warranted.   
 
2.4 Self-reported health-related quality of life  
Measurement of patient reported outcome measures (PROM), especially self-reported health-
related quality of life (HRQOL) is often considered an essential part of clinical research 
(53;54). Measurement of HRQOL may demand significant resources as some instruments 
(questioners) are time-consuming, both for patients, researchers and clinicians. Many different 
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disease specific and unspecific instruments exist. There is a huge variation in the amount of 
validation and evidence supporting the instruments in use (55). An important aspect of the 
validation needed is to establish disease-specific correlations with other important prognosis 
indicators and outcome measures.   
 
Reduced pretreatment HRQOL have been clearly linked to reduced survival (53). Less is 
known about the relationship between postoperative HRQOL and survival after abdominal 
surgery, although some studies have indicated a positive association (56). While weight loss 
has been associated with reduced HRQOL (54), less is known about the impact of sarcopenia 
on HRQOL in upper abdominal surgery (57).  
 
Postoperative prognosis assessment is important, as information on disease stadium from the 
histopathological examination is more usually much more accurate than information obtained 
from preoperative examinations. In addition, patients often face difficult decisions after 
surgery (e.g. whether to receive adjuvant chemotherapy).Research has indicated that 
oncologic follow-up including routine imaging can cause increased anxiety (58) but many 
patients welcome regular visits to a physician (59).  Postoperative physical HRQOL is 
probably influenced by many factors and stage of the disease might be the most important. 
Nevertheless, postoperative HRQOL is also influenced by factors which are not necessarily 
directly related to the stage of disease, including functional impairment, pain and nutritional 
depletion.  If a relationship between postoperative HRQOL and survival can be validated, 
further research might reveal factors that could improve survival with very few unwanted side 




2.5  Postoperative complications and long-term survival 
Major complications after surgery may be fatal. Nonfatal complications may still have a 
negative effect on HRQOL (60), length-of-stay (LoS) (61), and resource utilization (61). In 
addition, reports have indicated that even for patients initially surviving the double hit of 
surgery and a subsequent major complication, long-term survival will still be negatively 
affected (62;63). Khuri et al showed that patients experiencing a complication from surgery 
had a markedly reduced long-term survival even when those who died within 30 days of their 
complication were excluded from analysis (62). This has led to speculations whether major 
complications could have long-standing suppressive effects on a patient’s immune system 
thereby rendering them more susceptible to cancer recurrence or another major disease (64). 
Their findings have been corroborated by several reports, but others again have failed to show 
this connection (65). 
 
A distinct association between socioeconomic status and both postoperative morbidity and 
survival after cancer surgery has been shown (66-68). The association between 
socioeconomic status and survival cannot be fully explained by differences in either disease-
stage or treatment, although these factors are thought to be significant (67). If these factors 
were the most important, one could hypothesize that the association would be weaker in 
societies with equal access to health care.     
 
A validation of the possible relationship between non-fatal postoperative complications and 
survival is important, but factors like differences in socioeconomic status have to be properly 
accounted for. Adherence to enhanced recovery protocols (ERPs) has been proven to reduce 
postoperative morbidity (69). If postoperative morbidity is clearly linked to survival after 
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cancer surgery, measures that have been proven to reduce morbidity such as ERPs (69) might 





This thesis seeks to clarify the following issues concerning recovery and survival after upper 
abdominal surgery: 
A. How do patients and dedicated professionals define recovery and which care elements 
are most crucial according to the same patients and professionals? 
B. How do pretreatment body composition indices (relative amount of skeletal muscle 
and adipose tissue) correlate with outcome after upper abdominal surgery? How does 
loss of lean or adipose tissue during treatment correlate with outcome after upper 
abdominal surgery? How do body composition indices correlate with disease severity? 
C. How does outcome after upper abdominal surgery correlate with new (body 
composition indices) compared to old (preoperative weight loss and serum-albumin) 
tools for risk/prognosis assessment? 
D.  How does survival after upper abdominal surgery correlate with pre- or postoperative 
self-reported health-related quality of life (HRQOL)? How does HRQOL correlate 
with other tools for risk/prognosis assessment? 
E. Does postoperative morbidity (complications) correlate with long-term survival after 





4.1 Questionnaire survey (Paper I, II) 
The questionnaire surveys were constructed within the ERAS (Enhanced Recovery After 
Surgery) Society collaboration.   
 
In the first survey, dedicated professionals were asked to rate eight recovery targets and 13 
care items on a Likert scale. The questionnaire was prepared for digital, web-based 
distribution by email and mailed to recipients between October and December 2012.  
 
Two select groups of dedicated professionals were targeted. The first group was delegates to 
the first international ERAS congress in Cannes, France in October 2012. The second group 
consisted of participants selected through a PubMed search with the following search terms: 
(”enhanced recovery” OR ”critical pathway” OR ”fast track”) AND (surgery OR operation 
OR resection OR *ectomy) for the latest five years in English. The resulting list of papers was 
hand searched to yield only papers with a clear relevance to ERAS in abdominal surgery.  
 
In the second survey, care providers and patients were approached with a questionnaire 
similar to the one used in the first survey. Patients received two questionnaires, preoperatively 
and 2-4 weeks after surgery. Care providers and patients were approached in three northern 
European university hospital centers; Tromsø (Norway), Edinburgh (United Kingdom) and 




4.2  Prospective cohort study (Paper III, IV) 
From 2001 to 2006, 447 patients were included in a Norwegian multicenter randomized 
controlled trial (RCT), which investigated normal food at will after major upper surgery (70). 
The dataset from that study was now treated as a single, prospective cohort. Survival data 
from the Norwegian Population Registry were retrieved during April 2012, six years after the 
last patient was included in the original trial.  
 
In addition to demographics and general clinical characteristics, the prospective database 
included specifically: patient-reported preoperative weight loss, preoperative serum-albumin, 
type of surgery, major postoperative complications and self-reported health-related quality of 
life (HRQOL).  
 
Major complications, within eight weeks after surgery were defined a priori in the original 
trial (70). The operative procedures were listed in the original publication (70). Patients were 
divided into the following disease categories: Gastroesophageal cancer, pancreatic cancer, 
other cancer (mainly malignant liver tumors and liver metastasis) and non-cancer. 
 
Preoperative weight loss was calculated from patients’ usual pre-morbid weight as they 
reported it - with no time limit, and current weight as scaled preoperatively at trial enrolment. 
It was dichotomized into >5% or ≤5% weight loss. Preoperative serum-albumin was 
dichotomized into <35.0 g/l or ≥35.0 g/l.  
 
Self-reported HRQOL was assessed preoperatively at trial enrollment and eight weeks after 
surgery. The validated Norwegian translation (71) of  the generic health-related quality of life 
instrument: Short Form 36 (SF-36), Norwegian version 1.2, was utilized.  While SF-36 is not 
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a disease-specific instrument, it has been used and validated in a wide range of malignant and 
non-malignant diseases (55). SF-36 contains thirty-six questions that produce eight scales. 
These scales are; physical functioning, role limitation (caused by physical problems), bodily 
pain, general health, vitality, social functioning, role limitation (caused by emotional 
problems) and mental health. These scales were aggregated to produce a summary physical 
HRQOL score (Physical Component Summary, PCS) and a summary mental HRQOL score 
(Mental Component Summary, MCS) (72). These norm-based scores have a mean of 50 and a 
standard deviation of 10 in general adult populations (72). Reduced HRQOL were defined as 
summary scores lower than 50.    
 
Digitally stored computer tomography (CT) images for initial routine diagnostics and staging 
were analyzed using Slice-O-Matic software V4.2 (Tomovision, Montreal-Canada) which 
permitted specific tissue demarcation using Houndsfield unit threshold of -29 to +150 for 
skeletal muscles (73), -150 to -50 for visceral adipose tissue (74), and -190 to -30 for 
subcutaneous adipose tissue (73). Cross-sectional areas (cm2) were calculated for each tissue 
by summing tissue pixels and multiplying by the pixel surface area. A transverse CT image 
from the third lumbar vertebrae (L3) was assessed for each scan and tissue areas estimated 
(75). All CT images were analyzed by one single trained observer who was blinded to all 
clinical data. Cross-sectional area was normalized for stature (cm2/m2) and the following 
indices were calculated: L3 Skeletal muscle index (L3 SMI), L3 Visceral adipose tissue index 
(L3 VAT) and L3 Subcutaneous adipose tissue index (L3 SAT). CT images used for analysis 
were retrieved from routine examinations performed within three months preoperatively.  
 
The cut-offs for L3 SMI suggested by Martin et al (50) were utilized: L3 SMI <41 cm2/m2 for 
women, L3 SMI <43 cm2/m2 for men with BMI <25 kg/m2 and L3 SMI <53 cm2/m2 for men 
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with BMI ≥25kg/m2. We also used the cut-offs suggested first by Mourtzakis et al (47) and 
later in an international consensus paper (10). This cut-off corresponds to skeletal muscle 
mass two standard deviations from that of healthy young adults (39 cm2/m2 for women and 55 
cm2/m2 for men) (10). Preoperative weight loss, serum-albumin and L3 SMI were analyzed 
both as dichotomous and continuous variables. L3 VAT and L3 SAT were analyzed only as 
continuous variables.   
 
In the first paper, all patients with complete data sets for preoperative serum-albumin and 
weight loss were included in the analysis. A subgroup analysis was performed on patients 
with available preoperative CT images.  
 
In the second paper, patients without any pre- or postoperative HRQOL data were excluded 
from further analysis.  
 
4.3 Retrospective case series study (Paper V) 
A complete cohort of all patients who underwent gastric resection for adenocarcinoma in    
the four-year period 2008-2011 in two Scandinavian referral centers (University hospital of     
Northern Norway, Tromsø, Norway and Karolinska University Hospital at Huddinge, 
Stockholm, Sweden) was retrospectively analyzed (n=137). Information on general 
characteristics, comorbidity, histopathological stage, chemotherapy treatment and -toxicity, 
postoperative complications and overall survival were retrieved from patient files.  
 
The following investigations were performed separately: 
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- Tissue change during neoadjuvant chemotherapy (NAC): Patients with CT images of 
sufficient quality from the diagnostic/staging and the preoperative CT examination 
were included in this analysis. 
- Preoperative body composition indices in relation to disease severity and clinical 
outcome: All patients with preoperative CT images of sufficient quality were included.  
- Postoperative tissue change: Patients with CT images from the preoperative CT 
examination and furthermore one CT examination performed between one and twelve 
months postoperatively were included.  
 
Body composition analysis based on computed tomography images are described in section 
4.2.  Total whole-body amount of lean tissue (FFM=fat-free mass) and fat tissue (FM=fat 
mass) were estimated from the following formulas (47): 
FFM (kg) = 0.3 x L3 Skeletal muscle area (cm2) + 6.06 
FM (kg) = 0.042 x L3 Visceral and subcutaneous adipose tissue area (cm2) + 11.2 
Estimated total tissue (lean and fat tissue combined) was also calculated.  
 
Dose Limiting Toxicity (DLT) was defined as chemotherapeutic side effects leading to 
chemotherapy dose reduction or abandonment (18). Complications were classified by the 
Accordion classification (76;77). Severe postoperative complications as a dichotomous 
outcome were defined as one or more Accordion III or higher complication (76;77).  
 
4.4 Register study (Paper VI) 
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A database of surgical procedures, major postoperative complications and survival were 
extracted from the Norwegian Patient Registry (NPR). Data on educational level were 
extracted from Statistics Norway, the Norwegian central bureau of statistics.  
 
We identified all resections of the esophagus, stomach and pancreas in the six-year period 
from January 1, 2008 to December 1, 2013. Data on overall survival until June 30, 2014 were 
retrieved. Operations and reoperations were identified from their Nomesco classification of 
Surgical Procedures (NCSP) code (2014).  
 
Only cases with an appropriate cancer diagnosis (ICD-10: C15*, C16* and C25* respectively, 
where * denotes all sub-codes) applied within eight weeks from surgery were included. 
Emergency cases were excluded from to obtain a cohort of patients that were reasonably fit at 
index surgery.  
 
Overall survival was defined as survival from index surgery. Major complications were 
defined as equivalent to Accordion score IV or higher (76;77), i.e. a re-operation in general 
anesthesia for a complication, and/or single- or multiple organ failure (76;77). We did not 
attempt to identify complications with lower severity score, as these complications would be 
difficult to extract from NPR data.  
 
All stays in this database (containing an eligible index operation) were coupled with any 
subsequent stay at any Norwegian hospital with an admission date within 28 days of 
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discharge from the index stay. Hospital stays (single or coupled) containing one or more 
major complications were identified.  This was done by identification of one of the following 
procedure codes at index or subsequent stay: Reoperation for wound dehiscence (JWA00), for 
deep infection (JWC00/01), for deep hemorrhage (JWE00/01/02), for anastomotic dehiscence 
(JWF00/01) for other causes (JWW96/97/98) or if a tracheostomy was performed 
(GBB00/03). Also, a major complication was identified from the use of one of the following 
diagnoses during index or subsequent stays: Bleeding, hematoma or circulatory shock 
following a procedure (T81.0/T81.1). 
 
 Educational level was divided into higher and lower education. Higher education was defined 
as education beyond primary and lower secondary school. Surgical resections were stratified 




5. METHODOLOGICAL DISCUSSION 
Our conclusions are based on two questionnaire surveys, one prospective cohort study (a 
long-term follow-up of a randomized clinical trial, one retrospective case series study and one 
register study. 
 
5.1 Questionnaire survey (Paper I, II) 
The response rate in the first survey was 50%. This is within acceptable limits of surveys of 
this kind (78), although a higher response rate would have been preferable. The preoperative 
response rate was very high in the second survey (100%) with some missing data 
postoperatively (19% lost in follow-up). In both surveys, most of the recovery targets and care 
items received a high rating, indicating that the surveys lacked discriminatory power. The 
sample sizes were small in both surveys. 
 
5.2 Prospective cohort study (Paper III, IV) 
To our knowledge, this is the first study to observe both health-related quality of life 
(HRQOL) and body composition in multicenter prospective upper abdominal surgery cohort. 




There were varying degrees of missing data on the different variables investigated. These 
varying degrees of missing data introduce possibilities for selection bias. Especially, there 
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were many missing CT images from the first couple of years in the cohort. Furthermore, 
preoperative and postoperative HRQOL data were missing to a varying extent.  
 
Heterogeneity in survival 
Our cohort lacked data on disease stage and did not exclusively consist of cancer patients. 
Heterogeneity in survival was high. Still, survival analysis was stratified on the different 
disease categories and the effect of the variables investigated (weight loss, serum-albumin, 
body composition indices and HRQOL) was similar in the different disease categories. 
 
5.3 Retrospective case series study (paper V) 
A limitation of this study was its retrospective design. This type of design allows for errors 
when data is classified into different variables, in this case for example when whether patients 
experienced dose-limiting toxicity or postoperative complications. These outcome variables 
were retrospectively determined based on information from the patient’s prospectively 
registered medical records.  
 
Number of patients 
Another limitation of this study was the relatively small number of patients included (n=137), 
especially the number of patients who received preoperative chemotherapy (n=58). There was 
little degree of missing data, but some patients lacked CT images of sufficient quality for 
body composition analyses. The relatively small number of patients analyzed may have 





Common biases of retrospective studies include selection bias and recall bias. Selection bias 
was limited in our study as our cohort consisted of all patients who underwent surgery for 
gastric adenocarcinoma in a four-year period in the two participating centers (University 
Hospitals of Tromsø, Norway and Huddinge - Stockholm, Sweden). This four – year interval 
were chosen due to the implementation of perioperative chemotherapy in the treatment of 
gastric adenocarcinoma in 2007 and to have sufficient observational time on all patients (three 
years). Recall bias was limited as information were prospectively recorded in the patient’s 
medical journals.  
 
5.4 Register study (paper VI) 
The Norwegian patients registry (NPR) used for this study has some limitations, the varying 
quality of data in this registry and the number of variables missing in this registry. For this 
reason, the only variables collected were age, gender, type of operation, educational level 
(information gathered from Statistics Norway – the Norwegian central bureau of statistics), 




This registry is national which limit the degree of potential selection bias, although there 
might be patients who were not included in our six – year cohort, due to limitations of our 
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algorithm (described in section 4.4). Also, there might be postoperative complications not 
detected due to limitations of our algorithm. Although such selection and interpretation biases 
may exist, they are probably occurring randomly. A comparison of the yield from our refined 
search strings with hand searched patient files in a four-year cohort at our own hospital (150 
patients) showed a 100% match in both number of resections and rate of major complications. 
 
Number of patients 
This study consisted of an unselected national cohort with almost 2000 patients, but the 
number of patients with higher educational level was relatively small (n=510). This might 
contribute to the lack of association between educational level and survival. 
 
5.5 Association and causation (Paper  III, IV, V and VI) 
All of the observational studies in this thesis (paper III, IV, V and VI) allows for analyses of 
association and not causation. It would be very difficult to investigate whether abnormal 
serum-albumin, preoperative weight loss, low muscle mass, visceral obesity or decreased 
health-related quality of life cause decreased survival after upper abdominal surgery as these 
exposures are newer randomized.  Can complications make patients more susceptible to 
cancer recurrence and therefore cause decreased longevity? This question can never be 
answered with a randomized human clinical trial. Sometimes causation may be evaluated 




6. OVERVIEW OF RESULTS 
 
6.1 Rating of recovery targets and care items among dedicated professionals (Paper I)  
The response rate was 50% of both congress participants and authors. Surgeons, anesthetists 
and nurses were represented. The recovery targets: To be completely free of nausea; To be 
independently mobile and To be able to eat and drink as soon as possible received the highest 
score irrespective of responder’s profession or region of origin. Equally, the care items: 
Optimizing fluid balance; Preoperative counseling and Promoting early and scheduled 
mobilization received the highest score across all groups.  
 
6.2 Rating of recovery targets and care items among caregivers and patients (Paper II)  
One hundred nine patients and 57 care providers completed the preoperative survey. Overall, 
both patients and care providers rated the majority of items as important and supported ERAS 
principles. The recovery target To be completely free of nausea and the care item 
Preoperative counseling were rated the highest by both patients and care providers. 
 
6.3 Risk factors, complications and survival (Paper III)  
There were 447 patients included in the original trial. Complete information on preoperative 
weight loss and serum-albumin was available for 369 patients (82.5%). Preoperative CT 
images of sufficient quality were available in 157 of these patients (157/369=42.5%).  
Preoperative serum-albumin <35 g/l and weight loss >5% were independently associated with 
reduced survival. There was no association between any of the preoperative body composition 
indices and reduced survival. Major postoperative complications were independently 
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associated with reduced survival but only as long as patients who died within 90 days were 
included in the analysis.  
 
6.4 Health-related quality of life (HRQOL) and survival (paper IV) 
A majority of the patients experienced improved mental HRQOL and, to a lesser extent, 
deteriorated physical HRQOL following surgery. There was a significant association between 
preoperative weight loss and reduced physical HRQOL.  No association between low muscle 
mass and HRQOL was observed. Reduced physical HRQOL both pre- and postoperatively, 
and reduced postoperative mental HRQOL was significantly associated with impaired 
survival. The association between HRQOL and survival was particularly strong for 
postoperative physical HRQOL. 
 
6.5 Body composition analyses and outcome in patients with resectable gastric 
adenocarcinoma (Paper V) 
Of the 137 patients who underwent gastric resection in the period, 70 patients (51.1%) 
patients died within three years. Neoadjuvant chemotherapy was given to 58 (42.3%) patients 
and forty (29.2%) patients suffered severe postoperative complications. There was a 
significant reduction in patients’ lean tissue during neoadjuvant chemotherapy (p=0.001), but 
no association between such loss and any recorded outcome including dose-limiting toxicity. 
Older age and female gender, but not advanced histopathological stage, was associated with 
lower preoperative skeletal muscle tissue index. Poorer survival was observed in patients with 
preoperative skeletal muscle tissue index within the lowermost quartile (HR=2.08, 95% 
CI=1.21-3.57, p=0.008) such association was also observed independently of disease stage 
(HR=1.91, 95% CI 1.11-3.28, p=0.019). There was no association between low preoperative 
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muscularity and impaired survival when any of the cut-offs established in other studies 
(47;50) were investigated.   A significant loss of both lean (p<0.001) and fat tissue (p<0.001) 
was observed postoperatively. 
 
6.6 Association between suffering major postoperative complications and decreased 
survival after major upper abdominal surgery (Paper VI) 
There were 1965 esophageal-, gastric- or pancreatic resections performed for cancer in 
Norway during 2008-2013. A total of 248 patients (12.6%) suffered major postoperative 
complications. Complications were associated with increased both early mortality (90 days 
mortality: OR=4.25, 95% CI=2.78-6.51), and overall survival when patients suffering early 
mortality were excluded (HR=1.23, 95% CI=1.01-1.23). Lower educational level was 
associated with increased rate of major postoperative complications (OR=1.41, 95% CI 1.02-
1.95). Educational level was not associated with survival and did not affect the association 






7. GENERAL DISCUSSION 
Avoidance of postoperative morbidity, fast recovery, improved quality of life and ultimately 
improved survival are essential goals in upper abdominal surgery. The first three goals are 
important in itself but the achievement of these goals may also lead to improved long-term 
survival, even in patients with aggressive upper abdominal malignant disease.  
 
Success in this setting is challenging, as upper abdominal surgery often involves complex 
procedures associated with postoperative morbidity and functional impairment. Patients are 
often weakened by their disease preoperatively and they may suffer from both cachexia and 
low muscularity. Therefore, both optimal operative and perioperative treatment are required. 
Optimal perioperative treatment involves evidence-based and individualized care based on 
proper risk assessment. Such care demands high-quality research, which again requires proper 
definitions of recovery and validated, objective and widely accepted risk-stratification tools.  
 
7.1 Defining recovery and the most crucial perioperative care item.   
Our research has demonstrated a striking uniformity in the way international expertise and 
patients scored the relative importance of recovery targets.  Functional recovery, as 
intolerance of food without nausea and regained mobility, was considered the most important 
target for recovery and might be used as one definition of recovery in future research and 
audits. Preoperative counseling seems to be the most important perioperative care item when 
combining the evaluation of both dedicated professionals and patients. This item is intuitively 
very important and has little or no side-effects, but the strength of evidence behind it is sparse 
(80-83). This might show that optimal care cannot be based randomized controlled trials 
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alone, good old “common-sense” is still important in the era of evidence-based medicine and 
Cochrane reviews.  
 
7.2 Risk assessment 
Traditional risk assessment tools 
There are several well-known global indicators of both increased risk of postoperative 
morbidity and impaired survival. Abnormal serum-albumin and preoperative self-reported 
weight loss might be the most widely accepted indicators in digestive surgery and their 
importance has been recognized for several decades (32-34). These indicators are inexpensive 
to utilize and they are easily available. However, abnormal serum-albumin can be hard to 
interpret as it is influenced by many factors. Assessment of preoperative weight loss relies on 
patients’ recollection of pre-morbid weight, which might be inaccurate.  
 
Despite these weaknesses, our research has again confirmed the importance of assessing 
preoperative serum-albumin and weight loss, as these indicators again proved to be globally 
associated with impaired survival after upper abdominal surgery. 
 
Novel risk assessment tools 
Patients with upper abdominal malignancies often suffer from cachexia and sarcopenia 





Cachexia is defined as “A multifactorial syndrome defined by an ongoing loss of skeletal 
muscle mass (with or without loss of fat mass) that cannot be fully reversed by conventional 
nutritional support and leads to progressive functional impairment” (10).  
 
Sarcopenia has no universally accepted definition, and the term is both used when referring to 
low muscularity (measured at one time-spot, for example preoperatively) and loss of skeletal 
muscle tissue (85;86).  
 
Body composition analyses (evaluating patients’ relative amount of skeletal muscle and 
adipose tissue) have existed for several decades. Such analyses have also been used to 
investigate changes in the same tissue. Body composition analyses have been utilized in many 
different fields of medicine including physiology, geriatric medicine, cardiology, respiratory 
medicine, oncology and surgery. Several methods for body composition analysis has been 
utilized including in vivo neutron activation analysis (IVNAA) (87), whole body dual energy 
x-ray densitometry (DXA) (47) and bioelectrical impedance analysis (BIA) (47). The most 
recent method is the measurement of specific tissue area on computed tomography (CT) or 
magnetic resonance (MR) images (47). This measurement is based on tissue demarcation and 
both whole body tissue estimates and tissue indices relative to patients’ stature can be created 
(47). Body composition analysis based on CT images are easily available in upper abdominal 
surgery as almost every patient will be subjected to one or several CT examinations during 
their course of treatment (47).    
 
Our research has demonstrated that tissue loss during perioperative treatment for gastric 
adenocarcinoma can be easily quantified. Patients seem to experience a substantial loss of 
tissue, but such loss is yet to be linked to outcome. Body composition indices do not seem to 
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represent global indicators of postoperative morbidity and impaired survival. However, in 
gastric adenocarcinoma, patients with the lowermost preoperative muscularity seem to have 
the poorest prognosis. This association seems to be independent of disease stage.  
 
Body composition analysis might be important tools of risk assessment and research, and 
there might be areas within digestive surgery in which these analyses has an especially 
important role (88), examples may include predicting pulmonary complications after 
esophagectomies (42) and pancreatic fistulas after pancreaticoduodenectomies (43;44). 
However, the cut-offs and clinical relevance have to be investigated and validated disease-
specifically. Global cut-offs do not seem to exist.   
 
7.3 Postoperative morbidity, health-related quality of life and survival 
Avoidance of complications is of the utmost importance as complications are associated with 
reduced health-related quality of life (60) and increased resource utilization (89). 
Complications may also preclude or delay adjuvant chemotherapy (90).  
 
Reports have indicated that complications may be associated with decreased long-term 
survival, also when patients with early mortality are excluded from analysis (62;65;91;92).  In 
this setting, it has been suggested that major complications could have long-standing 
suppressive effects on a patient’s immune system and thereby render them more susceptible to 
cancer recurrence (62;64;91;92). The association between postoperative complications and 
long-term survival has not been consistently confirmed in upper abdominal cancer surgery 




Our research has demonstrated that major postoperative complications are associated with 
both early mortality and decreased long-term survival after gastro-esophageal and pancreatic 
cancer surgery in a national perspective. Systematic quality improvement to avoid 
complications may improve the poor prognosis associated these cancers.  
 
Our research has also demonstrated an association between postoperative complications and 
physical health-related quality of life (HRQOL). Furthermore, a distinct association between 
postoperative HRQOL and long-term survival was observed. These findings emphasize the 
importance of avoiding postoperative complications. Identifying patients with reduced 
postoperative HRQOL and paying more attention to their functional impairments may 










8. MAIN CONCLUSIONS 
Recovery of mobility and GI function are the most important target of convalescence after 
surgery. The traditional global indicators of poor prognosis after surgery, preoperative weight 
loss and abnormal serum-albumin, are still valid today. There is a close correlation between 
functional impairment and prognosis after major upper abdominal surgery. Tissue loss during 
surgical and oncological treatment for upper abdominal cancer can be evaluated through 
routine CT examinations. Preoperative low muscularity is independently associated with poor 
prognosis after resection for gastric adenocarcinoma. However, preoperative body 
composition indices do not seem to be global indicators of poor prognosis as importance and 
cut-offs seem to vary with different diseases. Postoperative morbidity is associated with poor 




9. IDEAS FOR FURTHER RESEARCH IN UPPER ABDOMINAL SURGERY  
- Future research on convalescence after surgery might replace “length of stay” with 
“time to functional recovery” (recovery of GI function and mobility) as an outcome. 
- Clinically relevant and disease-specific cut-offs for skeletal muscle and visceral 
adipose tissue indices in surgical oncology should be developed and validated. 
Associations with disease-stage should be further explored. 
-  Treatment toxicity and effect (chemotherapeutics and antibiotics) in relation to the 
amount of skeletal and adipose tissue should be further explored. 
-  Tissue loss preoperatively (during neoadjuvant chemotherapy) and postoperatively in 
surgical oncology should be further explored together with clinical relevance of such 
loss (associations with morbidity and survival). 
- Tissue change (evaluated through body composition analyses) could be an outcome 
measure in future research on prehabilitation and rehabilitation.  
- Survival benefit of assessing postoperative HRQOL and functional recovery (and 
intervening on problems identified) should be explored. 
- Survival benefit (long-term survival) of implementing programs to reduce 
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